Please assess the completion status of the following clinical trial:

Trial Title: Anticoagulation With Enhanced Gastrointestinal Safety

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria for Patients:~* Enrollment with the Michigan Medicine anticoagulation monitoring service~* Currently prescribed warfarin with anticipated use for ≥90 days on day 1 of trial enrollment, according to the electronic health record documentation.~* Currently prescribed an antiplatelet medication (aspirin, clopidogrel, ticagrelor, or prasugrel) according to the electronic health record medication list~Inclusion Criteria for Clinicians:~* Cardiologists at Michigan Medicine who in the prior year had a face-to-face or virtual visit with a patient who meets eligibility criteria~* Michigan Medicine primary care providers for patients who meet eligibility criteria~* Clinicians in any specialty who are designated as the clinician of record with the anticoagulation clinic for a patient who meets eligibility criteria~Exclusion Criteria for Patients:~* Age less than 18~* Currently prescribed a PPI~* Documented intolerance or allergy to PPI use~* Left ventricular assist device~* Heart transplant~* Participation in a previous pilot study of these implementation strategies~Exclusion Criteria for Clinicians:~* Cardiologists specializing in electrophysiology or who saw the patient for a clinic visit related to a TAVI procedure unless they are the clinician of record for a patient followed by the anticoagulation service who does not have a Michigan Medicine PCP.~* Participation in a previous pilot study of these QI strategies

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Clinician Notification with Nurse Facilitation (CNNF) (Type: EXPERIMENTAL): None
- Wait List Control (Usual care) (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).